CDK9 and acute myeloid leukemia: In line with this, co-targeting of CDK7 and CDK9 synergistically downregulated expression of the oncogene MYC and the anti-apoptotic protein MCL-1 and induced apoptosis through p53 activation in models of acute myeloid leukaemia [103].